首页 | 本学科首页   官方微博 | 高级检索  
     


Safety Evaluation and Anti-Inflammatory Efficacy of Lacticaseibacillus paracasei PS23
Authors:Chin-Hao Li  Tai-Ying Chen  Chien-Chen Wu  Shih-Hsuan Cheng  Min-Yu Chang  Wei-Hong Cheng  Shih-Hau Chiu  Chien-Chi Chen  Ying-Chieh Tsai  Deng-Jye Yang  Jaw-Jou Kang  Po-Lin Liao
Abstract:Lacticaseibacillus paracasei strain PS23 (PS23) exhibits some probiotic properties. In this study, a genomic analysis of PS23 revealed no genes related to virulence or antibiotic resistance. Moreover, ornithine decarboxylase activity was not detected in vitro. In addition, PS23 was sensitive to the tested antibiotics. Genotoxicity tests for PS23 including the Ames test and chromosomal aberrations in vitro using Chinese hamster ovary cells and micronuclei in immature erythrocytes of ICR mice were all negative. Moreover, following a 28-day study involving repeated oral dose toxicity tests (40, 400, and 4000 mg/kg equal 1.28 × 1010, 1.28 × 1011, and 1.28 × 1012 CFU/kg body weight, respectively) using an ICR mouse model, no adverse effects were observed from any doses. In addition, supplementation with live or heat-killed PS23 ameliorates DSS-induced colonic inflammation in mice. Our findings suggest that PS23 is safe and has anti-inflammatory effects and may therefore have therapeutic implications.
Keywords:Lacticaseibacillus paracasei PS23   genome-based safety assessment   28-day repeated oral dose toxicity   genotoxicity test   no observed adverse effect level
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号